Path of least resistance. new drug development guidance needed from FDA
Huff, B.
Gmhc Treatment Issues the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 20(4-7): 12
2006
ISSN/ISBN: 1077-1824 PMID: 17228452 Document Number: 600647
Document emailed within 1 workday
Related Documents
Boe, O. 1972: Development of drug resistance in Gram-negative rods Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(2): 73-77Charmot, G.; Lapresle, C. 1986: Development of the drug resistance of Plasmodium falciparum in Africa Archives de l'Institut Pasteur de Tunis 63(1): 51-59
Farquharson, J. 1981: Introducing change: the path of least resistance Dimensions in Health Service 58(7): 23
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Dück, K.D. 1980: Development and drug correction of therapy resistance in chronic antihypertensive use Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 35(20): Supply 123-5
Kheĭlik, A.G.; Man'kovskiĭ, A.V. 1981: Relation of dysentery drug therapy to the development of antibiotic resistance in Shigella Antibiotiki 26(8): 606-607
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Larsen, J.L.; Nielsen, N.C. 1975: Influence of restrictive use of antibiotics on the development of drug resistance in intestinal Escherichia coli from pigs Nordisk Veterinaermedicin 27(7-8): 353-364
Zhou, Y.Q.; Ning, D.X. 1988: Inhibitory effect of artemisinine-sulfadoxine-pyrimethamine combination on the development of drug-resistance in Plasmodium berghei Zhongguo Yao Li Xue Bao 9(5): 453-457
Govorin, N.V.; Lozhkina, A.N. 1991: Antibodies to neuroleptics and their role in the mechanisms of the development of drug resistance in psychopharmacotherapy of patients with paranoid schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 91(7): 117-121
Krasil'nikov, M.A.; Shatskaia, V.A. 2001: Role of phosphatidylinositol signalling path in developing hormonal resistance in tumor cells Voprosy Onkologii 47(2): 218-223
Graham, S.M.; Masese, L.; Gitau, R.; Jalalian-Lechak, Z.; Richardson, B.A.; Peshu, N.; Mandaliya, K.; Kiarie, J.N.; Jaoko, W.; Ndinya-Achola, J.; Overbaugh, J.; McClelland, R.S. 2010: Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment Journal of Infectious Diseases 202(10): 1538-1542
O'Rourke, K. 2003: FDA guidance on antimicrobials aims to prevent resistance Journal of the American Veterinary Medical Association 223(12): 1714-5 1719
Gilbert, L.; Walker, L. 2002: Treading the path of least resistance: HIV/AIDS and social inequalities: a South African case study Social Science and Medicine (1982) 54(7): 1093-1110
Majlessipour, F.; Kwock, R.; Martin-Aragon, S.; Weinberg, K.I.; Avramis, V.I. 2001: Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities Anticancer Research 21(1a): 11-22
Simsek, M.; de Boer, N.K.H.; Mulder, C.J.J. 2018: Continued development of drugs: the path of thioguanine Nederlands Tijdschrift Voor Geneeskunde 162: D1757
Taylor, B.S.; Hunt, G.; Abrams, E.J.; Coovadia, A.; Meyers, T.; Sherman, G.; Strehlau, R.; Morris, L.; Kuhn, L. 2011: Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa AIDS research and human retroviruses 27(9): 945-956
Kovalev, A.A.; Tsvetaeva, D.A.; Grudinskaja, T.V. 2013: Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer Experimental Oncology 35(4): 287-290